Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Research & Development: 2011-2024

Historic Research & Development for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $69.3 million.

  • Veracyte's Research & Development fell 9.06% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year increase of 0.84%. This contributed to the annual value of $69.3 million for FY2024, which is 20.92% up from last year.
  • As of FY2024, Veracyte's Research & Development stood at $69.3 million, which was up 20.92% from $57.3 million recorded in FY2023.
  • Over the past 5 years, Veracyte's Research & Development peaked at $69.3 million during FY2024, and registered a low of $17.2 million during FY2020.
  • For the 3-year period, Veracyte's Research & Development averaged around $55.7 million, with its median value being $57.3 million (2023).
  • Data for Veracyte's Research & Development shows a peak YoY skyrocketed of 73.47% (in 2021) over the last 5 years.
  • Veracyte's Research & Development (Yearly) stood at $17.2 million in 2020, then surged by 73.47% to $29.8 million in 2021, then soared by 36.06% to $40.6 million in 2022, then soared by 41.13% to $57.3 million in 2023, then rose by 20.92% to $69.3 million in 2024.